| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/20/2014 | US20140342930 Methods for selective targeting |
| 11/20/2014 | US20140342405 Vascular endothelial growth factor 2 |
| 11/20/2014 | US20140342048 Sauces, spreads, cooking oils, and cooking fats made from various ingredients |
| 11/20/2014 | US20140342007 Methods of manufacturing bioactive gels from extracellular matrix material |
| 11/20/2014 | US20140342006 Methods for Preparing Injectable Protein Microparticle Suspensions |
| 11/20/2014 | US20140342004 Functionalized nanoparticles for intracellular delivery of biologically active molecules |
| 11/20/2014 | US20140342001 Medicaments |
| 11/20/2014 | US20140341997 Continuous process for preparing microspheres and microspheres prepared thereby |
| 11/20/2014 | US20140341972 Method to induce neovascular formation and tissue regeneration |
| 11/20/2014 | US20140341971 Composition for targeting dendritic cells |
| 11/20/2014 | US20140341944 Proteins comprising mrsa pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat mrsa infections |
| 11/20/2014 | US20140341931 Soluble cd27 (scd27) and the use thereof |
| 11/20/2014 | US20140341911 Prevention and Treatment of Amyloidogenic Disease |
| 11/20/2014 | US20140341900 Methods of treating cancer |
| 11/20/2014 | US20140341891 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| 11/20/2014 | US20140341890 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| 11/20/2014 | US20140341889 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| 11/20/2014 | US20140341888 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| 11/20/2014 | US20140341886 TREATMENT WITH ANTI ErbB2 ANTIBODIES |
| 11/20/2014 | US20140341883 Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
| 11/20/2014 | US20140341882 Pharmaceutical product for preventing or treating alzheimer's disease |
| 11/20/2014 | US20140341881 Use of serine protease inhibitors in the treatment of skin diseases |
| 11/20/2014 | US20140341879 Methods for the prevention or treatment of vessel occlusion injury |
| 11/20/2014 | US20140341877 Mcpip as wound therapy |
| 11/20/2014 | US20140341876 Method for the treatment of pulmonary disease and method of producing proteins of use therein |
| 11/20/2014 | US20140341866 Cell tissue gel containing collagen and hyaluronan |
| 11/20/2014 | US20140341858 Neuron generation, regeneration and protection |
| 11/20/2014 | US20140341852 Capsid-modified raav vector compositions and methods therefor |
| 11/20/2014 | US20140341846 Methods of inhibiting photoreceptor apoptosis |
| 11/20/2014 | US20140341844 Immunocytokines in combination with anti-erbb antibodies for the treatment of cancer |
| 11/20/2014 | US20140341842 Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione |
| 11/20/2014 | US20140341814 Compounds modulators of vegf activity and uses thereof |
| 11/20/2014 | US20140341804 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (pmsa) and uses thereof |
| 11/20/2014 | US20140341802 Provasopressin antagonists and uses thereof |
| 11/20/2014 | US20140341801 Inactivation of smooth muscle tissue |
| 11/18/2014 | US8889871 Hepatitis C virus inhibitors |
| 11/18/2014 | US8889844 Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 11/18/2014 | US8889838 Removal of serine proteases by treatment with finely divided silicon dioxide |
| 11/18/2014 | US8889836 Method for non-covalent immobilization of infectious prion protein |
| 11/18/2014 | US8889830 Hemoglobin-albumin complex, and artificial plasma expander and artificial oxygen carrier containing the complex |
| 11/18/2014 | US8889829 Methods of making a diagnostic composition and compositions therefrom |
| 11/18/2014 | US8889828 Conformations of divergent peptides with mineral binding affinity |
| 11/18/2014 | US8889826 Peptide antibiotics and methods for making same |
| 11/18/2014 | US8889745 Fibrous calcium pyrophosphate particles and methods of making and using same |
| 11/18/2014 | US8889712 IAP antagonists |
| 11/18/2014 | US8889681 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies |
| 11/18/2014 | US8889680 Treatment or prevention of fungal infections with PDK1 inhibitors |
| 11/18/2014 | US8889634 Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species |
| 11/18/2014 | US8889633 Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| 11/18/2014 | US8889632 Stabilized p53 peptides and uses thereof |
| 11/18/2014 | US8889631 Disruptors of early/recycling endosomes |
| 11/18/2014 | US8889630 Method for hair regrowth using Granulocyte-Colony Stimulating Factor |
| 11/18/2014 | US8889629 Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events |
| 11/18/2014 | US8889627 Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
| 11/18/2014 | US8889626 Triple cross-linked collagen, method of manufacturing the same, and use thereof |
| 11/18/2014 | US8889625 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 11/18/2014 | US8889624 Thrombin-free composition containing freeze-dried, virally inactivated FXIa and serpins and/or kininogen |
| 11/18/2014 | US8889623 Immunostimulatory nanoparticles and related compositions, methods and systems |
| 11/18/2014 | US8889622 Methods of inhibiting seizure in a subject |
| 11/18/2014 | US8889621 Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia |
| 11/18/2014 | US8889620 Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factor |
| 11/18/2014 | US8889619 Fusion protein of Exendin-4 and its analog, preparation method and use thereof |
| 11/18/2014 | US8889618 C-terminal fragments of glucagon-like peptide-1 (GLP-1) |
| 11/18/2014 | US8889616 MUC1 based glycolipopeptide vaccine with adjuvant |
| 11/18/2014 | US8889615 Methods for promoting epithelialization and healing of chronic wounds |
| 11/18/2014 | US8889426 Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia |
| 11/18/2014 | US8889396 Methods and compositions for improving growth of meat-type poultry |
| 11/18/2014 | US8889393 Method and kit for sequential isolation of nucleotide species from a sample |
| 11/18/2014 | US8889374 Recombinant codon optimised factor H |
| 11/18/2014 | US8889356 CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
| 11/18/2014 | US8889194 Smoking cessation with body weight maintenance and nutritional supplement |
| 11/18/2014 | US8889188 Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses |
| 11/18/2014 | US8889174 Zero-order prolonged release coaxial implants |
| 11/18/2014 | US8889170 Implantable device having a coating with a triblock copolymer |
| 11/18/2014 | US8889153 Combination of immunomodulator and anti-pathogenic agent |
| 11/18/2014 | US8889151 Methods for treating headache |
| 11/18/2014 | US8889149 Use of flagellin to prevent and treat gram negative bacterial infection |
| 11/18/2014 | US8889143 Ii-key/HER-2/neu hybrid cancer vaccine |
| 11/18/2014 | US8889136 Multiple-variable dose regimen for treating TNFα-related disorders |
| 11/18/2014 | US8889135 Methods of administering anti-TNFα antibodies |
| 11/18/2014 | US8889134 Modulators of Candida hyphal morphogenesis and uses thereof |
| 11/18/2014 | US8889133 Methods of treating diabetes with Dll4 antagonists |
| 11/18/2014 | US8889131 NOTCH inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof |
| 11/18/2014 | US8889129 Antidotes for factor Xa inhibitors and methods of using the same |
| 11/18/2014 | US8889128 Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases |
| 11/18/2014 | US8889127 Targeted protein replacement for the treatment of lysosomal storage disorders |
| 11/18/2014 | US8889126 Methods and compositions for treating neuropathies |
| 11/18/2014 | US8889125 Treatment of Huntington's disease |
| 11/18/2014 | US8889119 Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy |
| 11/18/2014 | US8889118 Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
| 11/18/2014 | US8889114 Composition and method for the inhibition of postoperative adhesions severity |
| 11/18/2014 | US8889106 Non-alcohol mouthwash composition without chemical antibacterial medicament |
| 11/18/2014 | US8889099 Methods and compositions for delivering peptides |
| 11/18/2014 | US8887721 Attenuation of vasoactive oxygen carrier-induced vasoconstriction |
| 11/13/2014 | US20140336780 Extracellular Matrix (ECM) Structures for Tissue Regeneration |
| 11/13/2014 | US20140336610 Methods and devices for point of use mixing of pharmaceutical formulations |
| 11/13/2014 | US20140336595 PERIPHERAL ADMINISTRATION OF PROTEINS INCLUDING TGF-beta SUPERFAMILY MEMBERS FOR TREATMENT OF SYSTEMIC DISORDERS AND DISEASE |
| 11/13/2014 | US20140336562 Presbyopia Treatment by Lens Alteration |
| 11/13/2014 | US20140336443 Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use |
| 11/13/2014 | US20140336359 Synthetic peptides for treatment of bacterial infections |